Clearance of technetium-99m-DTPA in pulmonary sarcoidosis

Autor:	Katerina M. Antoniou, Demosthenes Bouros, Kostas Perisinakis, Nikolaos Tzanakis, K.E. Symvoulakis, Katerina Malagari, N. Karkavitsas, Nikos M. Siafakas
Jazyk:	angličtina
Rok vydání:	2016
Předmět:	Adult Male Pulmonary and Respiratory Medicine medicine.medical_specialty Sarcoidosis radionuclear scan DTPA clearance lcsh:Medicine Pulmonary function testing FEV1/FVC ratio Pulmonary sarcoidosis Sarcoidosis Pulmonary DLCO medicine Humans Prospective Studies Radionuclide Imaging Lymph node Aged Lung business.industry lcsh:R Middle Aged respiratory system medicine.disease Respiratory Function Tests respiratory tract diseases medicine.anatomical_structure Spirometry Practice Guidelines as Topic HRCT Technetium Tc 99m Pentetate Female Radiography Thoracic Radiology Radiopharmaceuticals Tomography X-Ray Computed Cardiology and Cardiovascular Medicine Nuclear medicine business Technetium-99m
Zdroj:	Monaldi Archives for Chest Disease, Vol 65, Iss 3 (2016) Scopus-Elsevier
ISSN:	2532-5264 1122-0643
Popis:	Background. The aim of this study was to explore the possible association of the lung clearance of 99mTc- DTPA scan with HRCT lung abnormalities and with the pulmonary function tests [PFTs] in patients with sarcoidosis. Methods. We studied prospectively 15 patients [5 males, 10 females] of median age 46yr [range 27-67] with histologically proved sarcoidosis. HRCT scoring included the sum of the severity and extent of lymph node enlargement and parenchymal involvement. Results. The mean DTPA clearance half-time [Ï„ 1/2
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ec055f11a74098cfcb596948dbb0da6 https://www.monaldi-archives.org/index.php/macd/article/view/559 Zobrazit plný text záznamu